首页 > 最新文献

Infektsionnye Bolezni最新文献

英文 中文
Purulent meningitis and ischemic stroke resulted from large vessel occlusion in a child with generalized infection caused by Haemophilus influenzae 一例流感嗜血杆菌引起全身感染的儿童大血管闭塞引起的化脓性脑膜炎和缺血性中风
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-3-137-146
Е. Gorelik, N. Skripchenko, A. Vilnits, N. V. Marchenko, YU. P. Vasilieva, A. Astapova, E. Skripchenko, K. Markova, V. Voitenkov
The problem of generalized infection caused by Haemophilus influenzae is highly relevant to pediatric practice because of the disease severity and diversity of clinical manifestations. Purulent meningitis is the most common and most severe invasive form of infection caused by Haemophilus influenzae type b (Hib) and accounts for 50% of all cases. Purulent meningitis in children is characterized by high mortality and high incidence of residual neurological complications that often result in disability. The main cause if it is neurological complications in the acute period of the disease. In this article, we report a case of generalized Hib-infection, purulent meningitis, and a rare complication–thrombosis and occlusion of the large vessels, which caused acute cerebral ischemia/hypoxia. The combination of modern diagnostic methods, primarily neuroimaging, allowed us to verify the diagnosis at an early stage and ensured timely initiation of the appropriate therapy in order to prevent ischemic/hypoxic brain lesions. Parenteral injections of medications that increase the resistance of neurons and glial cells to hypoxia, such as cytoflavin, reduced neuronal damage in the acute period and residual neurological disorders during convalescence. Key words: vaccination, Haemophilus influenzae, purulent meningitis, children, complications, cytoflavin.
流感嗜血杆菌引起的全身性感染问题与儿科实践高度相关,因为疾病的严重性和临床表现的多样性。化脓性脑膜炎是由b型流感嗜血杆菌(Hib)引起的最常见和最严重的侵袭性感染,占所有病例的50%。儿童化脓性脑膜炎的特点是高死亡率和高发生率的残余神经系统并发症,往往导致残疾。其主要原因是急性期的神经系统并发症。在本文中,我们报告一例广泛性hib感染,化脓性脑膜炎和罕见的并发症-血栓形成和大血管闭塞,导致急性脑缺血/缺氧。现代诊断方法的结合,主要是神经影像学,使我们能够在早期阶段验证诊断,并确保及时开始适当的治疗,以防止缺血性/缺氧脑损伤。静脉注射增加神经元和神经胶质细胞对缺氧的抵抗力的药物,如细胞黄素,可以减少急性期的神经元损伤和恢复期残留的神经紊乱。关键词:疫苗接种,流感嗜血杆菌,化脓性脑膜炎,儿童,并发症,细胞黄素
{"title":"Purulent meningitis and ischemic stroke resulted from large vessel occlusion in a child with generalized infection caused by Haemophilus influenzae","authors":"Е. Gorelik, N. Skripchenko, A. Vilnits, N. V. Marchenko, YU. P. Vasilieva, A. Astapova, E. Skripchenko, K. Markova, V. Voitenkov","doi":"10.20953/1729-9225-2022-3-137-146","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-3-137-146","url":null,"abstract":"The problem of generalized infection caused by Haemophilus influenzae is highly relevant to pediatric practice because of the disease severity and diversity of clinical manifestations. Purulent meningitis is the most common and most severe invasive form of infection caused by Haemophilus influenzae type b (Hib) and accounts for 50% of all cases. Purulent meningitis in children is characterized by high mortality and high incidence of residual neurological complications that often result in disability. The main cause if it is neurological complications in the acute period of the disease. In this article, we report a case of generalized Hib-infection, purulent meningitis, and a rare complication–thrombosis and occlusion of the large vessels, which caused acute cerebral ischemia/hypoxia. The combination of modern diagnostic methods, primarily neuroimaging, allowed us to verify the diagnosis at an early stage and ensured timely initiation of the appropriate therapy in order to prevent ischemic/hypoxic brain lesions. Parenteral injections of medications that increase the resistance of neurons and glial cells to hypoxia, such as cytoflavin, reduced neuronal damage in the acute period and residual neurological disorders during convalescence. Key words: vaccination, Haemophilus influenzae, purulent meningitis, children, complications, cytoflavin.","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67728677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rationale for antiepidemic measures aimed to prevent focal incidence of COVID-19 in dormitories (on the example of Moscow) 旨在防止COVID-19在宿舍集中发生的防疫措施的理由(以莫斯科为例)
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-1-23-31
A. Zadoroshnyy, N. Pshenichnaya, V. Akimkin, V. Maleev
During the COVID-19 pandemic, many infection foci were registered in dormitories. Therefore, it is critical to have a clear understanding of the effectiveness of antiepidemic measures (AEMs) that appear to be one of the most important method to prevent the spread of the virus. Objective. To provide a scientific rationale for AEMs used to prevent the spread of COVID-19 in dormitories. Materials and methods. We compared the epidemic process in 5 representative COVID-19 foci, depending on AEMs initiated at these foci. The t-test was used to check the statistical hypothesis (p ≤ 0.05). Results. The epidemiological analysis demonstrated that the severity of COVID-19 epidemic process correlated with the effectiveness of AEMs. Absence of AEMs during focus formation promoted rapid spread of the virus among residents on all floors of the dormitory. The epidemic process in these dormitories was characterized by a chronic course with a high incidence rate. The implementation of a complex of AEMs when first COVID-19 cases were registered prevented the formation of a large infection focus and facilitated its timely isolation. Conclusion. Our findings suggest that AEMs are the main measures to limit focal incidence of COVID-19 in the dormitories of Moscow. Key words: infection focus, dormitory, antiepidemic measures, COVID-19
在2019冠状病毒病大流行期间,许多感染疫源地都在宿舍登记。因此,清楚地了解防疫措施(AEMs)的有效性是至关重要的,这似乎是防止病毒传播的最重要方法之一。目标。为使用AEMs预防COVID-19在宿舍传播提供科学依据。材料和方法。根据在这些疫源地发起的AEMs,我们比较了5个代表性疫源地的流行过程。采用t检验检验统计学假设(p≤0.05)。结果。流行病学分析表明,疫情过程的严重程度与AEMs的有效性相关。在焦点形成过程中缺乏紧急医疗服务,促进了病毒在宿舍所有楼层的居民中迅速传播。这些宿舍的流行过程具有慢性和高发病率的特点。在首次登记COVID-19病例时,实施综合医疗辅助管理,防止了大型感染焦点的形成,并有助于及时隔离。结论。我们的研究结果表明,AEMs是限制莫斯科宿舍COVID-19疫源地发病率的主要措施。关键词:感染焦点;宿舍;防疫措施
{"title":"Rationale for antiepidemic measures aimed to prevent focal incidence of COVID-19 in dormitories (on the example of Moscow)","authors":"A. Zadoroshnyy, N. Pshenichnaya, V. Akimkin, V. Maleev","doi":"10.20953/1729-9225-2022-1-23-31","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-1-23-31","url":null,"abstract":"During the COVID-19 pandemic, many infection foci were registered in dormitories. Therefore, it is critical to have a clear understanding of the effectiveness of antiepidemic measures (AEMs) that appear to be one of the most important method to prevent the spread of the virus. Objective. To provide a scientific rationale for AEMs used to prevent the spread of COVID-19 in dormitories. Materials and methods. We compared the epidemic process in 5 representative COVID-19 foci, depending on AEMs initiated at these foci. The t-test was used to check the statistical hypothesis (p ≤ 0.05). Results. The epidemiological analysis demonstrated that the severity of COVID-19 epidemic process correlated with the effectiveness of AEMs. Absence of AEMs during focus formation promoted rapid spread of the virus among residents on all floors of the dormitory. The epidemic process in these dormitories was characterized by a chronic course with a high incidence rate. The implementation of a complex of AEMs when first COVID-19 cases were registered prevented the formation of a large infection focus and facilitated its timely isolation. Conclusion. Our findings suggest that AEMs are the main measures to limit focal incidence of COVID-19 in the dormitories of Moscow. Key words: infection focus, dormitory, antiepidemic measures, COVID-19","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67727247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Mycoplasma pneumoniae antibiotic resistance based on data obtained in the Tula region 基于图拉地区数据的肺炎支原体抗生素耐药性分析
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-1-127-130
T. Chestnova, A.S. Ignatkova, O. A. Kuznetsova, A. V. Mariyko
Objective. To study the prevalence of mutations causing resistance to macrolides in Mycoplasma pneumoniae in the Tula region and compare the data with similar studies from European and Asian countries. Material and methods. A retrospective study of 76 samples of biological materials (nasal and pharynx swabs) was conducted. The materials were collected from the patients with an established diagnosis: the lower respiratory tract infection (pneumonia, bronchitis). All the patients included in the study were treated in specialized infections units and clinics of the Tula region for the period 2017–2018. Antibiotic therapy was not conducted before the initial survey. All the samples contained M. pneumoniae DNA. A real-time polymerase chain reaction (real-time PCR) technology was used to detect the DNA of M. pneumoniae in the materials. The analysis of mutations in the 23S rRNA gene was performed at the Scientific Research Institute of Antimicrobial Chemotherapy in Smolensk. During the study, a modified real-time PCR technique with the effect of the fluorescence quenching of the probe with a primer (patent No. 2646123) was used. The statistical analysis was carried out with the MS Excel software package. Results. It was identified that 9 samples (11.84%) had mutations associated with resistance to macrolides. Two samples had the A2059G mutation, while seven samples had the A2058G mutation (numbering of nucleotide sequences in the M. pneumoniae rRNA gene was compiled following E. coli numbering). The data obtained by us are slightly higher than the mean values of European countries and are significantly lower according to the studies of Asian countries. Conclusions. Provided unique data on the prevalence and identification of mutations of macrolide-resistant strains of M. pneumoniae in one of the regions of the Central Federal District is a contribution to the study of antibiotic-resistant strains of M. pneumoniae in Russia and all over the world. There is a necessity to monitor antibiotic resistance in other regions and increase diligence on atypical forms of community-acquired pneumonia since the co-infection of M. pneumoniae patients with COVID-19 leads to a deterioration in the condition and an increase in the duration of treatment. Keywords: community-acquired pneumonia, macrolides mycoplasmas, mutations of antibiotic resistance
目标。目的研究图拉地区肺炎支原体对大环内酯类药物耐药突变的流行情况,并与欧洲和亚洲国家的类似研究进行比较。材料和方法。对76份生物材料样本(鼻咽拭子)进行回顾性研究。资料收集自确诊为下呼吸道感染(肺炎、支气管炎)的患者。所有纳入研究的患者在2017-2018年期间在图拉地区的专门感染单位和诊所接受治疗。在初步调查前未进行抗生素治疗。所有样本均含有肺炎支原体DNA。采用实时聚合酶链反应(real-time PCR)技术检测材料中肺炎支原体DNA。23S rRNA基因突变分析是在斯摩棱斯克的抗菌化疗科学研究所进行的。在研究过程中,采用了一种改良的实时PCR技术,利用引物对探针进行荧光猝灭(专利号:2646123)。采用MS Excel软件包进行统计分析。结果。9份样本(11.84%)存在与大环内酯类耐药相关的突变。2份样本存在A2059G突变,7份样本存在A2058G突变(肺炎支原体rRNA基因核苷酸序列按照大肠杆菌编号编制)。我们得到的数据略高于欧洲国家的平均值,而根据亚洲国家的研究,我们得到的数据明显低于欧洲国家的平均值。结论。在中央联邦区的一个地区提供了关于肺炎支原体大环内酯耐药菌株的流行和突变鉴定的独特数据,对俄罗斯和全世界肺炎支原体抗生素耐药菌株的研究做出了贡献。有必要监测其他地区的抗生素耐药性,并加强对非典型社区获得性肺炎的监测,因为肺炎支原体患者与COVID-19合并感染会导致病情恶化和治疗时间延长。关键词:社区获得性肺炎,大环内酯类支原体,抗生素耐药性突变
{"title":"Analysis of Mycoplasma pneumoniae antibiotic resistance based on data obtained in the Tula region","authors":"T. Chestnova, A.S. Ignatkova, O. A. Kuznetsova, A. V. Mariyko","doi":"10.20953/1729-9225-2022-1-127-130","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-1-127-130","url":null,"abstract":"Objective. To study the prevalence of mutations causing resistance to macrolides in Mycoplasma pneumoniae in the Tula region and compare the data with similar studies from European and Asian countries. Material and methods. A retrospective study of 76 samples of biological materials (nasal and pharynx swabs) was conducted. The materials were collected from the patients with an established diagnosis: the lower respiratory tract infection (pneumonia, bronchitis). All the patients included in the study were treated in specialized infections units and clinics of the Tula region for the period 2017–2018. Antibiotic therapy was not conducted before the initial survey. All the samples contained M. pneumoniae DNA. A real-time polymerase chain reaction (real-time PCR) technology was used to detect the DNA of M. pneumoniae in the materials. The analysis of mutations in the 23S rRNA gene was performed at the Scientific Research Institute of Antimicrobial Chemotherapy in Smolensk. During the study, a modified real-time PCR technique with the effect of the fluorescence quenching of the probe with a primer (patent No. 2646123) was used. The statistical analysis was carried out with the MS Excel software package. Results. It was identified that 9 samples (11.84%) had mutations associated with resistance to macrolides. Two samples had the A2059G mutation, while seven samples had the A2058G mutation (numbering of nucleotide sequences in the M. pneumoniae rRNA gene was compiled following E. coli numbering). The data obtained by us are slightly higher than the mean values of European countries and are significantly lower according to the studies of Asian countries. Conclusions. Provided unique data on the prevalence and identification of mutations of macrolide-resistant strains of M. pneumoniae in one of the regions of the Central Federal District is a contribution to the study of antibiotic-resistant strains of M. pneumoniae in Russia and all over the world. There is a necessity to monitor antibiotic resistance in other regions and increase diligence on atypical forms of community-acquired pneumonia since the co-infection of M. pneumoniae patients with COVID-19 leads to a deterioration in the condition and an increase in the duration of treatment. Keywords: community-acquired pneumonia, macrolides mycoplasmas, mutations of antibiotic resistance","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67727624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of recombinant IFN-α2b on the phenotype of neutrophil granulocyte subpopulations in patients with COVID-19 重组IFN-α2b对COVID-19患者中性粒细胞亚群表型的影响
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-1-43-51
I. Nesterova, V. Gorodin, G. Chudilova, V. N. Chapurina, V. A. Matushkina, R.Yu. Gabdrakhmanova, L. Lomtatidze, S. Kovaleva, V. V.V.Malinovskaya, Т. Semenenko
Investigation of molecular mechanisms associated with interferon (IFN) production and receptor function of neutrophil granulocytes (NGs) in COVID-19 is highly relevant because it can be promising in the search for new therapeutic strategies targeting NGs and their reactivity to restore and strengthen the innate immune response against SARS-CoV-2. Objective. To assess the effects of recombinant IFN-α2b on the phenotype of CD16+IFNα/βR1–CD119+, CD16+IFNα/βR1+CD119–, and CD16+IFNα/βR1+CD119+ NGs from peripheral blood of patients with COVID-19 in an in vitro experiment. Patients and methods. We analyzed blood samples from 31 patients with a mean age of 61 years (range: 57;71 years) with moderate COVID-19. We assessed the number of CD16+IFNα/βR1–CD119+, CD16+IFNα/βR1+CD119–, and CD16+IFNα/βR1+CD119+ NGs, receptor density (FC 500, ‘Beckman Coulter,’ USA), phagocytic activity of NGs before and after incubation with recombinant IFN-α2b. We also measured serum levels of several cytokines, including IFNα, IFNγ, IL-6, IL-8 (ELISA, ‘Vektor-Best’ LLC). The control group comprised 22 adult healthy individuals with a mean age of 58 years (range: 57; 70 years). Results. Patients with moderate COVID-19 demonstrated low serum levels of IFNα and IFNγ along with elevated levels of IL-6 and IL-8. We observed transformation of 3 phenotypes among NG subpopulations: CD16+IFNα/βR1–CD119+, CD16+IFNα/βR1+CD119-, and CD16+IFNα/βR1+CD119+. We observed positive remodulating effects of recombinant IFN-α2b on the number and phenotype of NG subpopulations and their phagocytic activity in our in vitro experiment. Conclusion. Recombinant IFN-α2b demonstrated positive effects in in vitro experiments; therefore, it can be considered in the future as a potential therapeutic tool for moderate COVID-19. Restoration of type I IFN might be an effective treatment option for COVID-19, because it can promote faster virus elimination, restore normal functioning of the IFN system, and have positive regulatory effects on the phenotype of NG subpopulations. Key words: neutrophil granulocytes, subpopulations, COVID-19, phenotype, recombinant interferon α2b
研究与COVID-19中中性粒细胞(NGs)干扰素(IFN)产生和受体功能相关的分子机制具有重要意义,因为它可能有助于寻找针对NGs及其反应性的新治疗策略,以恢复和加强针对SARS-CoV-2的先天免疫应答。目标。目的:探讨重组IFN-α2b对新冠肺炎患者外周血CD16+IFNα/βR1 - CD119+、CD16+IFNα/βR1+CD119 -、CD16+IFNα/βR1+CD119+ NGs表型的影响。患者和方法。我们分析了31例平均年龄61岁(范围:57岁;71岁)的中度COVID-19患者的血液样本。我们评估了重组IFN-α2b孵育前后CD16+IFNα/βR1 - CD119+、CD16+IFNα/βR1+CD119 -和CD16+IFNα/βR1+CD119+ NGs的数量、受体密度(FC 500, ' Beckman Coulter ', '美国)、NGs的吞噬活性。我们还测量了几种细胞因子的血清水平,包括IFNα, IFNγ, IL-6, IL-8 (ELISA, ' vector - best ' LLC)。对照组包括22名健康成人,平均年龄58岁(范围:57岁;70年)。结果。中度COVID-19患者血清IFNα和IFNγ水平低,IL-6和IL-8水平升高。我们在NG亚群中观察到3种表型的转化:CD16+IFNα/βR1 - CD119+, CD16+IFNα/βR1+CD119-和CD16+IFNα/βR1+CD119+。在体外实验中,我们观察到重组IFN-α2b对NG亚群的数量、表型及吞噬活性有正向调节作用。结论。重组IFN-α2b在体外实验中表现出积极作用;因此,它可以被认为是未来中度COVID-19的潜在治疗工具。恢复I型IFN可能是COVID-19的有效治疗选择,因为它可以促进更快的病毒消除,恢复IFN系统的正常功能,并对NG亚群的表型具有积极的调节作用。关键词:中性粒细胞,亚群,COVID-19,表型,重组干扰素α2b
{"title":"Effects of recombinant IFN-α2b on the phenotype of neutrophil granulocyte subpopulations in patients with COVID-19","authors":"I. Nesterova, V. Gorodin, G. Chudilova, V. N. Chapurina, V. A. Matushkina, R.Yu. Gabdrakhmanova, L. Lomtatidze, S. Kovaleva, V. V.V.Malinovskaya, Т. Semenenko","doi":"10.20953/1729-9225-2022-1-43-51","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-1-43-51","url":null,"abstract":"Investigation of molecular mechanisms associated with interferon (IFN) production and receptor function of neutrophil granulocytes (NGs) in COVID-19 is highly relevant because it can be promising in the search for new therapeutic strategies targeting NGs and their reactivity to restore and strengthen the innate immune response against SARS-CoV-2. Objective. To assess the effects of recombinant IFN-α2b on the phenotype of CD16+IFNα/βR1–CD119+, CD16+IFNα/βR1+CD119–, and CD16+IFNα/βR1+CD119+ NGs from peripheral blood of patients with COVID-19 in an in vitro experiment. Patients and methods. We analyzed blood samples from 31 patients with a mean age of 61 years (range: 57;71 years) with moderate COVID-19. We assessed the number of CD16+IFNα/βR1–CD119+, CD16+IFNα/βR1+CD119–, and CD16+IFNα/βR1+CD119+ NGs, receptor density (FC 500, ‘Beckman Coulter,’ USA), phagocytic activity of NGs before and after incubation with recombinant IFN-α2b. We also measured serum levels of several cytokines, including IFNα, IFNγ, IL-6, IL-8 (ELISA, ‘Vektor-Best’ LLC). The control group comprised 22 adult healthy individuals with a mean age of 58 years (range: 57; 70 years). Results. Patients with moderate COVID-19 demonstrated low serum levels of IFNα and IFNγ along with elevated levels of IL-6 and IL-8. We observed transformation of 3 phenotypes among NG subpopulations: CD16+IFNα/βR1–CD119+, CD16+IFNα/βR1+CD119-, and CD16+IFNα/βR1+CD119+. We observed positive remodulating effects of recombinant IFN-α2b on the number and phenotype of NG subpopulations and their phagocytic activity in our in vitro experiment. Conclusion. Recombinant IFN-α2b demonstrated positive effects in in vitro experiments; therefore, it can be considered in the future as a potential therapeutic tool for moderate COVID-19. Restoration of type I IFN might be an effective treatment option for COVID-19, because it can promote faster virus elimination, restore normal functioning of the IFN system, and have positive regulatory effects on the phenotype of NG subpopulations. Key words: neutrophil granulocytes, subpopulations, COVID-19, phenotype, recombinant interferon α2b","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67727393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Defects in the interferon system associated with a deficiency of natural killers and T-cells in patients with COVID-19 新冠肺炎患者干扰素系统缺陷与天然杀伤剂和T细胞缺乏相关
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-2-23-32
I. Nesterova, V. Gorodin, G. Chudilova, V. N. Chapurina, V. A. Matushkina, L. Lomtatidze, Т. Semenenko, V. Malinovskaya, A. N. Shuvalov, E. N. Vyzhlova
Identification of interrelated innate and sensitive immune responses in COVID-19 is an important step in the development of targeted therapeutic approaches, which is relevant. Objective. To clarify the features of the defect in the function of NK cells, T lymphocytes, the interferon system in patients with moderate and severe COVID-19. Patients and methods. Tests of the peripheral blood of 50 COVID-19 patients aged 61(57–71) and having the moderate and severe disease were performed. The following parameters were measured: the quantity of CD3+CD19–, CD3+CD4+, CD3+CD8+ T lymphocytes, NK – (CD3–CD16+CD56+), and TNK – CD3+CD16+CD56+ with expression density considered membrane receptors (MFI) (FC 500 Beckman Coulter, USA), the levels of IFN-α, IFN-γ, IL-6, TNF-α cytokines (IFA). Results. Combined immunodeficiency associated with quantitative and functional defects in NK, T lymphocytes and their subsets was revealed in moderate and severe COVID-19. An imbalance of cytokines has been established: blockade of the production of IFN-α and IFN-γ against the background of a significant increase in IL-6 and TNF-α, which negatively affects both the number and functionality of the participants in the immune response and is associated with a severe course and poor prognosis of COVID-19. Conclusion. The data obtained demonstrate the need to develop new strategies and tactics for the treatment of COVID-19, including replacement systemic therapy with recombinant IFN-α2b in combination with antioxidants (Viferon®) in adequate therapeutic doses, aimed at restoring the normal functioning of T lymphocytes, NK and the interferon system. Key words: COVID-19, interferons, moderate and severe disease course, NK cells, T lymphocytes
在COVID-19中识别相关的先天和敏感免疫反应是开发靶向治疗方法的重要一步,这是相关的。目标。目的:明确中、重度COVID-19患者NK细胞、T淋巴细胞、干扰素系统功能缺损的特点。患者和方法。对50例61岁(57 ~ 71岁)中重度新冠肺炎患者进行外周血检测。测量以下参数:CD3+CD19 -, CD3+CD4+, CD3+CD8+ T淋巴细胞,NK - (CD3 - CD16+CD56+), TNK - CD3+CD16+CD56+表达密度考虑膜受体(MFI) (FC 500 Beckman Coulter, USA)的数量,IFN-α, IFN-γ, IL-6, TNF-α细胞因子(IFA)的水平。结果。在中重度COVID-19中发现了与NK、T淋巴细胞及其亚群数量和功能缺陷相关的联合免疫缺陷。已经建立了细胞因子的不平衡:在IL-6和TNF-α显著升高的背景下,阻断IFN-α和IFN-γ的产生,这对免疫应答参与者的数量和功能产生负面影响,并与COVID-19的严重病程和不良预后相关。结论。获得的数据表明,需要开发新的治疗COVID-19的策略和战术,包括以足够的治疗剂量使用重组IFN-α2b联合抗氧化剂(Viferon®)替代系统性治疗,旨在恢复T淋巴细胞、NK和干扰素系统的正常功能。关键词:COVID-19,干扰素,中重度病程,NK细胞,T淋巴细胞
{"title":"Defects in the interferon system associated with a deficiency of natural killers and T-cells in patients with COVID-19","authors":"I. Nesterova, V. Gorodin, G. Chudilova, V. N. Chapurina, V. A. Matushkina, L. Lomtatidze, Т. Semenenko, V. Malinovskaya, A. N. Shuvalov, E. N. Vyzhlova","doi":"10.20953/1729-9225-2022-2-23-32","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-2-23-32","url":null,"abstract":"Identification of interrelated innate and sensitive immune responses in COVID-19 is an important step in the development of targeted therapeutic approaches, which is relevant. Objective. To clarify the features of the defect in the function of NK cells, T lymphocytes, the interferon system in patients with moderate and severe COVID-19. Patients and methods. Tests of the peripheral blood of 50 COVID-19 patients aged 61(57–71) and having the moderate and severe disease were performed. The following parameters were measured: the quantity of CD3+CD19–, CD3+CD4+, CD3+CD8+ T lymphocytes, NK – (CD3–CD16+CD56+), and TNK – CD3+CD16+CD56+ with expression density considered membrane receptors (MFI) (FC 500 Beckman Coulter, USA), the levels of IFN-α, IFN-γ, IL-6, TNF-α cytokines (IFA). Results. Combined immunodeficiency associated with quantitative and functional defects in NK, T lymphocytes and their subsets was revealed in moderate and severe COVID-19. An imbalance of cytokines has been established: blockade of the production of IFN-α and IFN-γ against the background of a significant increase in IL-6 and TNF-α, which negatively affects both the number and functionality of the participants in the immune response and is associated with a severe course and poor prognosis of COVID-19. Conclusion. The data obtained demonstrate the need to develop new strategies and tactics for the treatment of COVID-19, including replacement systemic therapy with recombinant IFN-α2b in combination with antioxidants (Viferon®) in adequate therapeutic doses, aimed at restoring the normal functioning of T lymphocytes, NK and the interferon system. Key words: COVID-19, interferons, moderate and severe disease course, NK cells, T lymphocytes","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67727758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of targeted antiviral therapy for acute respiratory viral infections in the COVID-19 pandemic COVID-19大流行急性呼吸道病毒感染靶向抗病毒治疗的可行性
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-3-104-112
K. Omarova, L. Balykova, N. Pshenichnaya, D. N. Zemskov, K. Zaslavskaya, A. V. Taganov, P. A. Belyy
The aim of this study was to analyze the efficacy and safety of using etiotropic therapy with favipiravir and molnupiravir that can selectively bind and inhibit not only SARS-CoV-2 proteins but also other RNA-containing pathogens of acute respiratory diseases. High transmission of pathogens, the risk of becoming chronic, frequent complications, cases of co-infection with several pathogens, which can lead to a more severe course of the disease, insufficient vaccination effectiveness, all this requires additional strategies for both prevention and treatment of acute respiratory viral infections. RNA-dependent RNA polymerase (RdRp), which has no equivalent in human cells, is involved in RNA synthesis and is an excellent therapeutic target for diseases caused by RNA viruses, including SARS-CoV-2. The long process of drug development and the “reuse” of drugs approved for other indications or successfully tested in terms of safety and tolerability pose the challenge of rapid establishment of an effective drug, including for the treatment of severe cases of COVID-19. Key words: COVID-19, SARS-CoV-2, RNA-dependent RNA polymerase (RdRp), favipiravir, molnupiravir
本研究的目的是分析favipiravir和molnupiravir使用致病因疗法的有效性和安全性,这两种药物不仅可以选择性结合和抑制SARS-CoV-2蛋白,还可以选择性结合和抑制其他含rna的急性呼吸道疾病病原体。病原体的高度传播、成为慢性疾病的风险、频繁的并发症、与多种病原体合并感染的病例(可能导致更严重的病程)、疫苗接种效力不足,所有这些都需要预防和治疗急性呼吸道病毒感染的额外战略。RNA依赖性RNA聚合酶(RdRp)参与RNA合成,是包括SARS-CoV-2在内的RNA病毒引起的疾病的良好治疗靶点,在人类细胞中没有相应的RNA依赖性RNA聚合酶(RdRp)。药物开发的漫长过程以及批准用于其他适应症或在安全性和耐受性方面成功测试的药物的“重复使用”构成了快速开发有效药物的挑战,包括用于治疗COVID-19重症病例的药物。关键词:COVID-19, SARS-CoV-2, RNA依赖性RNA聚合酶(RdRp), favipiravir, molnupiravir
{"title":"Feasibility of targeted antiviral therapy for acute respiratory viral infections in the COVID-19 pandemic","authors":"K. Omarova, L. Balykova, N. Pshenichnaya, D. N. Zemskov, K. Zaslavskaya, A. V. Taganov, P. A. Belyy","doi":"10.20953/1729-9225-2022-3-104-112","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-3-104-112","url":null,"abstract":"The aim of this study was to analyze the efficacy and safety of using etiotropic therapy with favipiravir and molnupiravir that can selectively bind and inhibit not only SARS-CoV-2 proteins but also other RNA-containing pathogens of acute respiratory diseases. High transmission of pathogens, the risk of becoming chronic, frequent complications, cases of co-infection with several pathogens, which can lead to a more severe course of the disease, insufficient vaccination effectiveness, all this requires additional strategies for both prevention and treatment of acute respiratory viral infections. RNA-dependent RNA polymerase (RdRp), which has no equivalent in human cells, is involved in RNA synthesis and is an excellent therapeutic target for diseases caused by RNA viruses, including SARS-CoV-2. The long process of drug development and the “reuse” of drugs approved for other indications or successfully tested in terms of safety and tolerability pose the challenge of rapid establishment of an effective drug, including for the treatment of severe cases of COVID-19. Key words: COVID-19, SARS-CoV-2, RNA-dependent RNA polymerase (RdRp), favipiravir, molnupiravir","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67727832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enterovirus infections: current state of the problem 肠道病毒感染:问题的现状
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-3-92-97
N. Tkhakushinova, T. Shaturina
In this review, we analyze the whole spectrum of the current state of the problem of enterovirus infection in the world and in one of the regions of the Russian Federation, namely Krasnodar region. We discuss the currently used classification of enterovirus infections, clinical manifestations, new approaches to diagnosis, treatment, and prevention. Key words: enterovirus infection, serotype, poliovirus
在这篇综述中,我们分析了全世界和俄罗斯联邦的一个地区,即克拉斯诺达尔地区肠道病毒感染问题的整个现状。我们讨论目前肠病毒感染的分类、临床表现、诊断、治疗和预防的新方法。关键词:肠道病毒感染,血清型,脊髓灰质炎病毒
{"title":"Enterovirus infections: current state of the problem","authors":"N. Tkhakushinova, T. Shaturina","doi":"10.20953/1729-9225-2022-3-92-97","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-3-92-97","url":null,"abstract":"In this review, we analyze the whole spectrum of the current state of the problem of enterovirus infection in the world and in one of the regions of the Russian Federation, namely Krasnodar region. We discuss the currently used classification of enterovirus infections, clinical manifestations, new approaches to diagnosis, treatment, and prevention. Key words: enterovirus infection, serotype, poliovirus","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67728794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of anti-Helicobacter activity of Stimbifid Plus meta-prebiotic and Helinorm metabiotic Stimbifid Plus元益生元与Helinorm代谢物抗幽门螺杆菌活性的比较评价
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-3-71-82
I. Chicherin, I. Pogorelsky, I. Lundovskikh, E. Kolevatykh
Objective. Comparative evaluation of the anti-Helicobacter activity of Stimbifid Plus meta-prebiotic and Helinorm metabiotic and the effectiveness of their oral administration for pathogen eradication in acute experimental helicobacteriosis in conventional white mice, using different microbiological methods. Materials and methods. The following microorganisms were used in the study: Helicobacter H. pylori strain 11, isolated from a biopsy sample of the gastric antral mucosa of a patient with gastritis, and its labeled rifampicin-resistant mutant H. pylori KM-11 (RifR), obtained by spontaneous mutagenesis, capable of growing on a solid culture medium with rifampicin at a concentration of 160 μg·mL–1; probiotic microorganisms – Escherichia coli M-17, Lactobacillus plantarum 8P-A3, Bifidobacterium bifidum No 1. H. pylori and H. pylori KM-11(RifR) were cultivated on a hemin-containing solid culture medium with special additives at a temperature of 37°C using an anaerobic cultivation system (anaerostat). The identification of microorganisms was carried out by morphological features and using bacterial biochemical identification kits. Experimental helicobacteriosis in conventional white mice was formed by oral administration of H. pylori bacterial suspension to animals against the background of the immunosuppressive effect of intramuscular administration of Dexamethasone. Stimbifid Plus meta-prebiotic and Helinorm metabiotic were used in the experiments. Electron microscopy of bacteria was performed using a scanning electron microscope. Statistical processing of the experimental results was carried out according to the Kerber method modified by I.P.Ashmarin and A.A.Vorobyov. Results. In vitro experiments established the anti-Helicobacter activity of Stimbifid Plus meta-prebiotic, which manifested itself as inhibition of the growth of H. pylori bacteria. In parallel experiments, the metabiotic Helinorm did not inhibit the growth of H. pylori bacteria, but only formed co-aggregates with them, diffusing into the culture medium. In experiments in vitro using the disk-diffusion method, evidence was obtained of the actual inhibition of the growth of probiotic microorganisms E. coli M-17, L. plantarum 8P-A3, B. bifidum No 1 by Helinorm metabiotic: L. plantarum 8P-A3 bacteria turned out to be the most sensitive to the effects of Helinorm metabiotic. When studying the survival of H. pylori bacteria in solutions of Stimbifid Plus meta-prebiotic and Helinorm metabiotic at a concentration of 8 mg·mL–1, a pronounced inhibitory effect of Stimbifid Plus meta-prebiotic was established, which manifested itself in the loss of H. pylori viability by 40 minutes of bacterial suspension incubation at a temperature of 37°C, while Helinorm metabiotic only reduced the number of H. pylori bacteria in suspension by 3 orders of magnitude at their initial concentration of 1.2 × 108 CFU mL–1. Experiments on conventional white mice with induced helicobacteriosis against the backgrou
目标。采用不同微生物学方法比较评价Stimbifid Plus元益生元与Helinorm代谢物对常规小鼠急性实验性幽门螺杆菌病的抗幽门螺杆菌活性及口服根除效果。材料和方法。本研究使用了以下微生物:从胃炎患者胃窦黏膜活检样本中分离的幽门螺杆菌11株及其标记的利福平耐药突变株KM-11 (RifR),通过自发诱变获得,能够在含有浓度为160 μg·mL-1的利福平固体培养基上生长;益生菌微生物——大肠杆菌M-17、植物乳杆菌8P-A3、两歧双歧杆菌1号。采用厌氧培养系统(anaerostat),在含血红素的固体培养基上添加特殊添加剂,在37℃的温度下培养幽门螺杆菌和幽门螺杆菌KM-11(RifR)。通过形态特征和细菌生化鉴定试剂盒对微生物进行鉴定。在肌肉注射地塞米松免疫抑制的背景下,动物口服幽门螺杆菌悬浮液形成常规小鼠实验性幽门螺杆菌病。实验采用stibifid Plus元益生元和Helinorm代谢物。采用扫描电镜对细菌进行电镜观察。根据i.p.a ashmarin和a.a.w orobyov改进的Kerber方法对实验结果进行统计处理。结果。体外实验证实了Stimbifid Plus元益生元的抗幽门螺杆菌活性,表现为抑制幽门螺杆菌的生长。在平行实验中,代谢物Helinorm不抑制幽门螺杆菌的生长,而只是与幽门螺杆菌形成共聚集体,扩散到培养基中。利用盘片扩散法进行体外实验,获得了Helinorm代谢物对益生菌微生物大肠杆菌M-17、植物乳杆菌8P-A3、两歧双歧杆菌No . 1生长的实际抑制证据,其中植物乳杆菌8P-A3细菌对Helinorm代谢物的影响最为敏感。在8 mg·mL-1浓度的Stimbifid Plus元益生菌和Helinorm metabiotics溶液中研究幽门螺杆菌的存活,发现Stimbifid Plus元益生菌对幽门螺杆菌有明显的抑制作用,在37℃条件下菌悬液孵育40分钟,幽门螺杆菌的生存能力下降。而Helinorm代谢物在初始浓度为1.2 × 108 CFU mL-1时,仅使悬液中幽门螺杆菌数量减少3个数量级。在动物肌肉注射地塞米松的背景下,对诱导幽门螺杆菌病的常规小白鼠进行实验,结果显示,Stimbifid Plus元益生菌抗幽门螺杆菌的活性在实验第9天达到根除病原菌的效果,并完全保存了实验动物正常胃肠道生物病变。在对感染幽门螺杆菌的动物进行的类似实验中,即使在实验的第21天,代谢物Helinorm也没有根除病原体,感染动物胃肠道微生物群的主要代表(大肠杆菌、乳酸杆菌和双歧杆菌)的数量显著减少。结论。通过体外实验和常规小鼠幽门螺杆菌病模型的建立,可以比较研究元益生元Stimbifid Plus和代谢物Helinorm与幽门螺杆菌病原菌之间的关系,以及它们对感染过程的影响、感染动物疾病结局的预后,以及口服药物根除动物幽门螺杆菌病原菌的前景。实验结果证实了Stimbifid Plus元益生元具有较高的抗幽门螺杆菌活性,并且需要进一步实验研究Helinorm代谢产物的特性,制造商提出将其作为实际使用的最有效的治疗幽门螺杆菌病的方法,考虑到纠正代谢结构的可能性,或在其成分中加入额外的手段来增强抗幽门螺杆菌活性。关键词:幽门螺杆菌,罗伊氏乳杆菌,元益生元Stimbifid plus,代谢性Helinorm,幽门螺杆菌病,根除
{"title":"Comparative evaluation of anti-Helicobacter activity of Stimbifid Plus meta-prebiotic and Helinorm metabiotic","authors":"I. Chicherin, I. Pogorelsky, I. Lundovskikh, E. Kolevatykh","doi":"10.20953/1729-9225-2022-3-71-82","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-3-71-82","url":null,"abstract":"Objective. Comparative evaluation of the anti-Helicobacter activity of Stimbifid Plus meta-prebiotic and Helinorm metabiotic and the effectiveness of their oral administration for pathogen eradication in acute experimental helicobacteriosis in conventional white mice, using different microbiological methods. Materials and methods. The following microorganisms were used in the study: Helicobacter H. pylori strain 11, isolated from a biopsy sample of the gastric antral mucosa of a patient with gastritis, and its labeled rifampicin-resistant mutant H. pylori KM-11 (RifR), obtained by spontaneous mutagenesis, capable of growing on a solid culture medium with rifampicin at a concentration of 160 μg·mL–1; probiotic microorganisms – Escherichia coli M-17, Lactobacillus plantarum 8P-A3, Bifidobacterium bifidum No 1. H. pylori and H. pylori KM-11(RifR) were cultivated on a hemin-containing solid culture medium with special additives at a temperature of 37°C using an anaerobic cultivation system (anaerostat). The identification of microorganisms was carried out by morphological features and using bacterial biochemical identification kits. Experimental helicobacteriosis in conventional white mice was formed by oral administration of H. pylori bacterial suspension to animals against the background of the immunosuppressive effect of intramuscular administration of Dexamethasone. Stimbifid Plus meta-prebiotic and Helinorm metabiotic were used in the experiments. Electron microscopy of bacteria was performed using a scanning electron microscope. Statistical processing of the experimental results was carried out according to the Kerber method modified by I.P.Ashmarin and A.A.Vorobyov. Results. In vitro experiments established the anti-Helicobacter activity of Stimbifid Plus meta-prebiotic, which manifested itself as inhibition of the growth of H. pylori bacteria. In parallel experiments, the metabiotic Helinorm did not inhibit the growth of H. pylori bacteria, but only formed co-aggregates with them, diffusing into the culture medium. In experiments in vitro using the disk-diffusion method, evidence was obtained of the actual inhibition of the growth of probiotic microorganisms E. coli M-17, L. plantarum 8P-A3, B. bifidum No 1 by Helinorm metabiotic: L. plantarum 8P-A3 bacteria turned out to be the most sensitive to the effects of Helinorm metabiotic. When studying the survival of H. pylori bacteria in solutions of Stimbifid Plus meta-prebiotic and Helinorm metabiotic at a concentration of 8 mg·mL–1, a pronounced inhibitory effect of Stimbifid Plus meta-prebiotic was established, which manifested itself in the loss of H. pylori viability by 40 minutes of bacterial suspension incubation at a temperature of 37°C, while Helinorm metabiotic only reduced the number of H. pylori bacteria in suspension by 3 orders of magnitude at their initial concentration of 1.2 × 108 CFU mL–1. Experiments on conventional white mice with induced helicobacteriosis against the backgrou","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67729084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic significance of detection and laboratory confirmation of inherited chromosomally integrated Human Herpesvirus 6A/B in newborns 新生儿遗传染色体整合型人疱疹病毒6A/B检测及实验室确认的经济意义
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-3-114-128
E. Domonova, E. Voronin, E. Melekhina, O. Chugunova, S. Cherkasova, A. Zaplatnikov, A. Dementyev, M. Tvorogova, V. Akimkin
Overdiagnosis of congenital infections caused by Human Herpesvirus 6A/B (HHV-6A/B) in newborns with an inherited chromosomally integrated (ici) HHV-6A/B creates an unreasonable economic burden for the healthcare system and society. We assessed economic significance of detection and laboratory confirmation of iciHHV-6A/B in newborns with congenital infections during their inpatient treatment in Moscow in 2020. The introduction of a new method based on the quantitative detection of HHV-6A/B DNA in patient’s whole blood sample, nail plates and/or hair follicles by a real-time polymerase chain reaction will result in an economic effect with a minimum ratio of 1:68, will reduce healthcare costs in Moscow and optimize the epidemiological surveillance of vertically congenital infections in the region. The total estimated economic costs averted (including costs of pharmacotherapy, as well as clinical, laboratory, and instrumental examinations and other medical procedures in maternity and obstetric hospitals) will be approximately 6 million rubles per year for Moscow. Key words: economic significance, economic costs averted, Human Herpesvirus 6A/B, inherited chromosomally integrated Human Herpesvirus 6 A/B, newborns, congenital infections
遗传性染色体整合(ici) HHV-6A/B新生儿中由人类疱疹病毒6A/B (HHV-6A/B)引起的先天性感染的过度诊断给医疗保健系统和社会造成了不合理的经济负担。我们评估了2020年莫斯科新生儿住院治疗期间先天性感染iciHHV-6A/B的检测和实验室确认的经济意义。引入一种基于实时聚合酶链反应定量检测患者全血样本、指甲板和/或毛囊中HHV-6A/B DNA的新方法,将产生最小比例为1:68的经济效果,将降低莫斯科的医疗成本,并优化该地区垂直先天性感染的流行病学监测。据估计,莫斯科每年可避免的经济费用总额(包括药物治疗以及产科医院的临床、化验室和仪器检查以及其他医疗程序的费用)约为600万卢布。关键词:经济意义,避免经济成本,人疱疹病毒6A/B,遗传染色体整合人疱疹病毒6A/B,新生儿,先天性感染
{"title":"Economic significance of detection and laboratory confirmation of inherited chromosomally integrated Human Herpesvirus 6A/B in newborns","authors":"E. Domonova, E. Voronin, E. Melekhina, O. Chugunova, S. Cherkasova, A. Zaplatnikov, A. Dementyev, M. Tvorogova, V. Akimkin","doi":"10.20953/1729-9225-2022-3-114-128","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-3-114-128","url":null,"abstract":"Overdiagnosis of congenital infections caused by Human Herpesvirus 6A/B (HHV-6A/B) in newborns with an inherited chromosomally integrated (ici) HHV-6A/B creates an unreasonable economic burden for the healthcare system and society. We assessed economic significance of detection and laboratory confirmation of iciHHV-6A/B in newborns with congenital infections during their inpatient treatment in Moscow in 2020. The introduction of a new method based on the quantitative detection of HHV-6A/B DNA in patient’s whole blood sample, nail plates and/or hair follicles by a real-time polymerase chain reaction will result in an economic effect with a minimum ratio of 1:68, will reduce healthcare costs in Moscow and optimize the epidemiological surveillance of vertically congenital infections in the region. The total estimated economic costs averted (including costs of pharmacotherapy, as well as clinical, laboratory, and instrumental examinations and other medical procedures in maternity and obstetric hospitals) will be approximately 6 million rubles per year for Moscow. Key words: economic significance, economic costs averted, Human Herpesvirus 6A/B, inherited chromosomally integrated Human Herpesvirus 6 A/B, newborns, congenital infections","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67727870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Systematic Review and Meta-Analysis of Mobile Phone Messaging Intervention on Vaccine Preventable Diseases 手机短信干预疫苗可预防疾病的系统评价与meta分析
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.20953/1729-9225-2022-1-82-90
Sharifah Fazlinda Syed Nor Sharifah Fazlinda Syed Nor, Nurul Afzan Aminuddin Nurul Afzan Aminuddin, Norain Ahmad Norain Ahmad, Mohd Rohaizat Hassan Mohd Rohaizat Hassan, Azmawati Mohammed Nawi Azmawati Mohammed Nawi, Norfazilah Ahmad Norfazilah Ahmad, Nicholas Tze Ping Pang Nicholas Tze Ping Pang, Azizan Omar Azizan Omar, Mohd Faizal Madrim Mohd Faizal Madrim, Khalid Mokti Khalid Mokti, Abdul Rahman Ramdzan Abdul Rahman Ramdzan, Syed Sharizman Syed Abdul Rahim Syed Sharizman Syed Abdul Rahim, Muhammad Saffree Jeffree Muhammad Saffree Jeffree
The re-emerging of vaccine preventable diseases is a global public health burgeoning issue. The incompleteness of vaccination or low uptake rate is due to low awareness of the importance of vaccines, forgetfulness, poor counselling, and health education from the healthcare providers. Mobile phone messaging reminder was one of the most studied interventions to overcome these problems in the last decade due to increasing usage of mobile phones in daily living activities. Therefore the aim of this study was to analyse the effectiveness of mobile phone messaging intervention on vaccination programmes of preventable diseases worldwide. Methods. A systematic literature search of randomised controlled trials on Cochrane database that were published for the past 10 years was done; in which 10 articles were selected for critical appraisal and qualitative synthesis. Out of the 10 articles, 9 articles were selected and proceeded with meta-analysis based on GRADE risk of bias assessment. Results. The overall vaccination coverage of mobile phone messaging in the intervention group was higher than the control group [61,586 (47.7%) versus 61,571(45.7%)] with significant pooled vaccination prevalence difference (PD) of 0.02 (CI 0.01, 0.03). In the subgroup analysis, the pooled PD of childhood vaccination coverage was not significant although significant pooled PD of 0.03 (CI 0.01, 0.04) was detected in the influenza vaccination coverage. Conclusion. This review and meta-analysis have strengthened the evidence that mobile phone messaging is an effective intervention method to increase vaccination coverage, especially for influenza vaccination. However, its effect on childhood vaccination coverage was inconclusive and needed more high quality research. Key words: mobile phone messaging; vaccine preventable illnesses; meta analysis; influenza
疫苗可预防疾病的重新出现是一个全球公共卫生的新兴问题。疫苗接种不完整或接种率低是由于对疫苗重要性的认识不高、遗忘、咨询不足以及卫生保健提供者的健康教育。在过去十年中,由于手机在日常生活活动中的使用越来越多,手机短信提醒是克服这些问题的研究最多的干预措施之一。因此,本研究的目的是分析手机短信干预全球可预防疾病疫苗接种计划的有效性。方法。对Cochrane数据库中过去10年发表的随机对照试验进行了系统的文献检索;其中选取10篇文章进行批判性评价和定性综合。从10篇文章中,选择9篇文章进行基于GRADE偏倚风险评估的meta分析。结果。干预组的手机短信总体疫苗接种率高于对照组[61,586(47.7%)对61,571(45.7%)],总疫苗接种率差异(PD)显著为0.02 (CI 0.01, 0.03)。在亚组分析中,尽管流感疫苗接种覆盖率检测到显著的0.03 (CI 0.01, 0.04),但儿童疫苗接种覆盖率的汇总PD不显著。结论。本综述和荟萃分析进一步证明,手机短信是提高疫苗接种覆盖率的有效干预方法,尤其是流感疫苗接种。然而,它对儿童疫苗接种覆盖率的影响尚无定论,需要更多高质量的研究。关键词:手机短信;疫苗可预防的疾病;元分析;流感
{"title":"A Systematic Review and Meta-Analysis of Mobile Phone Messaging Intervention on Vaccine Preventable Diseases","authors":"Sharifah Fazlinda Syed Nor Sharifah Fazlinda Syed Nor, Nurul Afzan Aminuddin Nurul Afzan Aminuddin, Norain Ahmad Norain Ahmad, Mohd Rohaizat Hassan Mohd Rohaizat Hassan, Azmawati Mohammed Nawi Azmawati Mohammed Nawi, Norfazilah Ahmad Norfazilah Ahmad, Nicholas Tze Ping Pang Nicholas Tze Ping Pang, Azizan Omar Azizan Omar, Mohd Faizal Madrim Mohd Faizal Madrim, Khalid Mokti Khalid Mokti, Abdul Rahman Ramdzan Abdul Rahman Ramdzan, Syed Sharizman Syed Abdul Rahim Syed Sharizman Syed Abdul Rahim, Muhammad Saffree Jeffree Muhammad Saffree Jeffree","doi":"10.20953/1729-9225-2022-1-82-90","DOIUrl":"https://doi.org/10.20953/1729-9225-2022-1-82-90","url":null,"abstract":"The re-emerging of vaccine preventable diseases is a global public health burgeoning issue. The incompleteness of vaccination or low uptake rate is due to low awareness of the importance of vaccines, forgetfulness, poor counselling, and health education from the healthcare providers. Mobile phone messaging reminder was one of the most studied interventions to overcome these problems in the last decade due to increasing usage of mobile phones in daily living activities. Therefore the aim of this study was to analyse the effectiveness of mobile phone messaging intervention on vaccination programmes of preventable diseases worldwide. Methods. A systematic literature search of randomised controlled trials on Cochrane database that were published for the past 10 years was done; in which 10 articles were selected for critical appraisal and qualitative synthesis. Out of the 10 articles, 9 articles were selected and proceeded with meta-analysis based on GRADE risk of bias assessment. Results. The overall vaccination coverage of mobile phone messaging in the intervention group was higher than the control group [61,586 (47.7%) versus 61,571(45.7%)] with significant pooled vaccination prevalence difference (PD) of 0.02 (CI 0.01, 0.03). In the subgroup analysis, the pooled PD of childhood vaccination coverage was not significant although significant pooled PD of 0.03 (CI 0.01, 0.04) was detected in the influenza vaccination coverage. Conclusion. This review and meta-analysis have strengthened the evidence that mobile phone messaging is an effective intervention method to increase vaccination coverage, especially for influenza vaccination. However, its effect on childhood vaccination coverage was inconclusive and needed more high quality research. Key words: mobile phone messaging; vaccine preventable illnesses; meta analysis; influenza","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67728054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infektsionnye Bolezni
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1